Healwell AI (AIDX) Q1 2025 earnings summary

Executive summary

• Q1 2025 revenue reached CAD 14.1 million, up 208% year-over-year, driven by organic growth, acquisitions, and 224% growth in AI and Data Science revenue.

• Orion Health acquisition closed April 1, 2025, expected to add CAD 100 million in annual SaaS and services revenue and drive Adjusted EBITDA profitability; Orion's results consolidated from Q2 onward.

• Leadership changes include James Lee as incoming CEO and a strengthened executive team to support integration and global scale.

• Six strategic acquisitions completed in 19 months, raising over CAD 100 million in capital.

• WELL Health Technologies exercised its call option, now holding 37% economic and 69% voting rights.

Financial highlights

• Q1 2025 revenue: CAD 14.1 million (Q1 2024: CAD 4.6 million), a 208% increase.

• Gross profit: CAD 6.5 million, up 226% year-over-year; gross margin improved to 46% from 44%.

• Adjusted EBITDA loss: CAD 3.3 million (Q1 2024: loss of CAD 2.5 million), reflecting investments in scaling and higher marketing costs.

• Net loss: CAD 14.1 million, impacted by CAD 2.5 million in Orion transaction costs and CAD 2.9 million in stock-based compensation.

• Cash at quarter-end: CAD 18.4 million, with CAD 86.6 million advanced/escrowed for Orion acquisition.

Outlook and guidance

• Orion Health expected to contribute CAD 25 million in Q2 2025 and CAD 100 million annually.

• Anticipate adjusted EBITDA positive for full year 2025, supported by Orion's contribution and cost optimization.

• Healthcare software segment projected to comprise over 70% of total revenue for the year.

• AI and data science, plus healthcare software, expected to approach 80% of total revenue as year progresses.